Skip to content

DR. MICHIEL GERITS

Active
Private limited companyfounded 2016active for 10 yearsMolenweg 77A, 3770 Riemst, BelgiumKBO/BCE: BE 0662.464.171

From the official registers: KBO 9 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

DR. MICHIEL GERITS has been active since 2016 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €331,299 and a net result of €93,818. Equity has been growing by about 8.1% per year since 2018. Its solvency ranks better than 70% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
DR. MICHIEL GERITSActiveChecked score 94/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 09-09-2016 Normal situation
Legal form
Private limited company
Registered office
Molenweg 77A, 3770 Riemst
Activity
General medical practice NACE 86210and 1 other
Establishment units
2.256.224.057 3740 Bilzen-Hoeselt, since 09-09-2016
2.256.224.156 3770 Riemst, since 09-09-2016
Financial year end
31 December
Peppol
Reachable since 31-10-2023
Company details

Board and ownership

Board
Office holders in the KBO
Board & ownership

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€144,501
▼ 2.0%
Turnover
≈ €260,000
estimated
Profit
€93,818
▼ 9.1%
Equity
€331,299
▼ 15.5%
Total assets
€414,868
▲ 3.2%
2025 accounts filed 29 days before the deadline
Filed on 02-07-2026at the National Bank
Financials
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 4.13, cash €57,336Equity €331,299 (79.9% of total assets)Figures for financial year 2025 (filed on 02-07-2026)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 50% of micro companies in human health (NACE 86)
Every signal that counts is listed under Signals.
Financial strength · tick: 2024
Strong
Solvency 100=
equity 79.9% of total assets
Liquidity 61-4
short-term debt 20.1% · cash 13.8%
Profitability 97-3
return on assets 22.6%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024lowest value 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025highest value 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €30,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 4.13 (32.12 in 2024), above the usual 1.5. Short-term debt is 20.1% and cash 13.8% of total assets. 20.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 39% on liquidity, 57% on profitability and 24% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 4.13, cash €57,336
NBB · annual accounts
lowers risk · Equity €331,299 (79.9% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 02-07-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-07-2026, 29 days ahead of the deadline.
NBB · 9 filings
Deviation from the deadline
2025
29 days early
2024
19 days late
2023
17 days late
2022
38 days early
2021
26 days late
2020
18 days early
2019
35 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 8 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 18 August (4 of the last 5 filed years within 47 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: 8 profitable years in a rowprofit 2025: €93,818 8 years View

Documents

Annual accounts at the NBB

All 9 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about DR. MICHIEL GERITS

What is the company number of DR. MICHIEL GERITS?
The company number of DR. MICHIEL GERITS is 0662.464.171. The VAT number is the same number with BE in front: BE 0662.464.171.
Where is DR. MICHIEL GERITS based?
The registered office is at Molenweg 77A, 3770 Riemst.Company details
What does DR. MICHIEL GERITS do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. MICHIEL GERITS?
The legal form of DR. MICHIEL GERITS is Private limited company (BV).
When was DR. MICHIEL GERITS founded?
DR. MICHIEL GERITS was founded on 09-09-2016.
Is DR. MICHIEL GERITS still active?
Yes, DR. MICHIEL GERITS is an active enterprise in the KBO register.
What is the turnover of DR. MICHIEL GERITS?
The turnover in financial year 2025 is ≈ €260,000. This figure is estimated from the gross margin of €144,501 and 30 comparable companies (NACE 86210). It probably lies between €210,000 and €320,000.Financials
Is DR. MICHIEL GERITS profitable?
In financial year 2025, DR. MICHIEL GERITS made a profit of €93,818.
Where can I find the annual accounts of DR. MICHIEL GERITS?
DR. MICHIEL GERITS filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of DR. MICHIEL GERITS due?
DR. MICHIEL GERITS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Comparable companies

These companies have the same main activity as DR. MICHIEL GERITS: general medical practice (NACE 86210). They are comparable in size and age: total assets between €355,000 and €448,000, founded between 2015 and 2018.

CompanyTotal assetsGross margin
DR. MICHIEL GERITS Riemst€414,868€144,501
Docteur Justine PERDAENS - Médecine Générale Chiny€420,351€138,038
DOC ACL Braine-l'Alleud€427,345€134,944
DOKTER EVA WITTEVRONGEL, HUISARTS Gent€447,726€150,699
Vanderhoydonck Nicolaas Antwerpen€402,533€142,778
Huisarts Van Renterghem Kwinten Gent€372,218€154,496
DR DE CEUNINCK Antwerpen€354,829€143,247
Full comparison

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure